190 related articles for article (PubMed ID: 36756039)
1. Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.
Kim HR; Shin HY; Yim TB; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
Evid Based Complement Alternat Med; 2023; 2023():4846770. PubMed ID: 36756039
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
[TBL] [Abstract][Full Text] [Related]
4. Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial.
Shin HY; Yim TB; Heo HM; Jahng GH; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2022 Dec; 22(1):318. PubMed ID: 36461035
[TBL] [Abstract][Full Text] [Related]
5. Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial.
Lee KH; Lee HG; Kwon S; Park SU; Jung WS; Moon SK; Park JM; Ko CN; Cho SY
BMC Complement Med Ther; 2023 Oct; 23(1):375. PubMed ID: 37872506
[TBL] [Abstract][Full Text] [Related]
6. Treatment evaluation of Kami Guibi-tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma-aminobutyric acid, and cerebral blood flow.
Cho SY; Kwon S; Shin HY; Kim HR; Kim JH; Park S; Ryu CW; Park JM; Edden RAE; Jahng GH
J Appl Clin Med Phys; 2021 Nov; 22(11):151-164. PubMed ID: 34633758
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of Kami Guibi-tang for cognitive impairment patients: A retrospective chart review.
Yim TB; Jeon GR; Lee HJ; Lee KH; Heo HM; Lee HG; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
Heliyon; 2024 Jan; 10(1):e23615. PubMed ID: 38187321
[TBL] [Abstract][Full Text] [Related]
8. Validity of the Montreal Cognitive Assessment (MoCA) Index Scores: a Comparison with the Cognitive Domain Scores of the Seoul Neuropsychological Screening Battery (SNSB).
Kim H; Yu KH; Lee BC; Kim BC; Kang Y
Dement Neurocogn Disord; 2021 Jul; 20(3):28-37. PubMed ID: 34354755
[TBL] [Abstract][Full Text] [Related]
9. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
[TBL] [Abstract][Full Text] [Related]
11. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients.
Ahn HJ; Chin J; Park A; Lee BH; Suh MK; Seo SW; Na DL
J Korean Med Sci; 2010 Jul; 25(7):1071-6. PubMed ID: 20592901
[TBL] [Abstract][Full Text] [Related]
12. Neurocircuitry of acupuncture effect on cognitive improvement in patients with mild cognitive impairment using magnetic resonance imaging: a study protocol for a randomized controlled trial.
Suh HW; Kim J; Kwon O; Cho SH; Kim JW; Kwak HY; Kim Y; Lee KM; Chung SY; Lee JH
Trials; 2019 May; 20(1):310. PubMed ID: 31146774
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects between 2 computerized cognitive training programs, Bettercog and COMCOG, on elderly patients with MCI and mild dementia: A single-blind randomized controlled study.
Lee GJ; Bang HJ; Lee KM; Kong HH; Seo HS; Oh M; Bang M
Medicine (Baltimore); 2018 Nov; 97(45):e13007. PubMed ID: 30407291
[TBL] [Abstract][Full Text] [Related]
14. Herbal Medicine for Patients with Cognitive Impairment: An Observational Study.
Choi Y; Kim AR; Lee JY; Kim HS; Yang C; Kim JK; Go Y; Jung IC
Neuropsychiatr Dis Treat; 2021; 17():3183-3194. PubMed ID: 34707357
[TBL] [Abstract][Full Text] [Related]
15. Effects of electroacupuncture combined with computer-based cognitive rehabilitation on mild cognitive impairment: study protocol for a pilot randomized controlled trial.
Kim JH; Han JY; Park GC; Lee JS
Trials; 2019 Aug; 20(1):478. PubMed ID: 31382998
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
[TBL] [Abstract][Full Text] [Related]
17. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
18. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
